Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 36, Issue 7, 1998, Pages 1969-1973

  Watterson, Simon A ^a   Wilson, Stuart M ^a   Yates, Malcolm D ^a   Drobniewski, Francis A ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ARTICLE; ASSAY; BACTERIUM DETECTION; BACTERIUM ISOLATION; COMPARATIVE STUDY; DEVICE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LUNG LAVAGE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0031809271     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.7.1969-1973.1998     Document Type: Article

References (32)

1. American Thoracic Society. 1997. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. J. Respir. Crit. Care Med. 156(Suppl.):S10-S12.
2. Bennett, D. E., A. R. Brady, J. Herbert, F. Drobniewski, M. Chadwick, I. Farrell, N. Lightfoot, B. Watt, R. Williams, A. Hayward, and J. M. Watson. 1996. Drug resistant TB in England and Wales 1993-1995. Thorax 51(Suppl. 3):S32.
3. Bodmer, T., G. Zürcher, P. Imboden, and A. Telenti. 1995. Mutation position and type of substitution in the β-subunit of the RNA polymerase influence the in-vitro activity of rifamycins in rifampicin resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother. 35:345-348.
4. Cohn, D. L., F. Bustreo, and M. C. Raviglione. 1997. Drug resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project. Clin. Infect. Dis. 24(Suppl. 1):S121-S130.
5. Collins, C. H., J. M. Grange, and M. D. Yates. 1997. Tuberculosis: bacteriology, organization and practice, 2nd ed. Butterworth-Heinemann, Oxford, United Kingdom.
6. Cooksey, R. C., G. P. Morlock, S. Glickman, and J. T. Crawford. 1997. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J. Clin. Microbiol. 35:1281-1283.
7. De Beenhouwer, H., Z. Lhiang, W. Jannes, L. Nfijs, L. Machtelinckx, R. Rossau, H. Traore, and F. Portaels. 1995. Rapid detection of rifampin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tubercle Lung Dis. 76:425-430.
8. Dolin, P. J., M. C. Raviglione, and A. Kochi. 1994. Global tuberculosis incidence and mortality during 1990-2000. Bull. W. H. O. 72:213-220.
9. Drobniewski, F. A. 1997. Is death inevitable with multiresistant TB plus HIV infection? Lancet 349:71-72.
10. Drobniewski, F. A., A. Pablos-Méndez, and M. C. Raviglione. 1997. Epidemiology of tuberculosis in the world. Semin. Respir. Crit. Care Med. 18:419-429.
11. Felmlee, T. A., Q. Liu, A. C. Whelen, D. Williams, S. S. Sommer, and D. H. Persing. 1995. Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-stranded conformational polymorphism and dideoxy fingerprinting. J. Clin. Microbiol. 33:1617-1623.
12. Heifets, L. B., and R. B. Good. 1994. Current laboratory methods for the diagnosis of tuberculosis, p. 85-110. In B. R. Bloom (ed.), Tuberculosis: protection, pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
13. Iseman, M. D. 1993. Treatment of multidrug-resistant tuberculosis. N. Engl. J. Med. 329:784-791.
14. Kapur, V., L.-L. Li, S. Iordanescu, M. R. Hamrick, A. Wanger, B. N. Kreiswirth, and J. M. Musser. 1994. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol. 32:1095-1098.
15. Kwok, S., and R. Higuchi. 1989. Avoiding false positives with PCR. Nature 339:237-238.
16. Lebrun, L., D. Mathieu, C. Saulnier, and P. Nordman. 1997. Limits of commercial tests for the diagnosis of pulmonary tuberculosis. Eur. Respir. J. 10:1874-1876.
17. Matsiota-Bernard, P., G. Vrioni, and E. Marinis. 1998. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J. Clin. Microbiol. 36:20-23.
18. McEvoy, M., and H. Maguire. 1995. Tuberculosis in London: a review, and an account of the work of the London Consultants in Communicable Disease Control Group Working Party. J. Hosp. Infect. 30(Suppl.):296-305.
19. Moore, M., I. A. Onorato, E. McCray, and K. G. Castro. 1997. Trends in drug-resistant tuberculosis in the United States, 1993-1996. JAMA 278:833-837.
20. Nash, K. A., and C. B. Inderlied. 1996. Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. Antimicrob. Agents Chemother. 40:1748-1730.
21. Nash, K. A., A. Gaytan, and C. B. Inderlied. 1997. Detection of rifampin resistance in Mycobacterium tuberculosis by means of a rapid, simple, and specific RNA/RNA mismatch assay. J. Infect. Dis. 176:533-536.
22. Raviglione, M. C., D. E. Snider, and A. Kochi. 1995. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 273: 220-226.
23. Roth, A., T. Scahberg, and H. Mauch. 1997. Molecular diagnosis of tuberculosis: current clinical validity and future perspectives. Eur. Respir. J. 10: 1877-1891.
24. Siddiqi, S. H. 1992. Radiometric (BACTEC) tests for slowly growing mycobacteria, p. 5.14.1-5.14.25. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook, vol. 1. American Society for Microbiology, Washington, D.C.
25. Taniguchi, H., H. Aramaki, Y. Nikaido, Y. Mizuguchi, M. Nakamura, T. Koga, and S. Yoshida. 1996. Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol. Lett. 144:103-108.
26. Telenti, A., N. Honoré, C. Bernasconi, J. March, A. Ortega, B. Heym, H. E. Takiff, and S. T. Cole. 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35:719-723.
27. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampin resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
28. Telenti, A., P. Imboden, F. Marchesi, T. Schmidheini, and T. Bodmer. 1993. Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob. Agents Chemother. 37:2054-2058.
29. Telles, M. A. S., and M. D. Yates. 1994. Single and double drug susceptibility testing of Mycobacterium avium complex and mycobacteria other than the tubercle (MOTT) bacilli by a micro-dilution broth minimum inhibitory concentration (MIC) method. Tubercle Lung Dis. 75:286-290.
30. WHO/IUATLD Global Project on Anti-Tuberculous Drug Resistance Surveillance. 1997. Anti-tuberculous drug resistance in the world. World Health Organization publication WHO/TB/97.229. World Health Organization, Geneva, Switzerland.
31. Williams, D. L., C. Waguespack, K. Eisenach, J. T. Crawford, F. Portaels, and M. Salfinger. 1994. Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother. 38:2380-2386.
32. Wilson, S. M., Z. Al-Suwaidi, R. McNerney, J. Porter, and F. Drobniewski. 1997. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat. Med. 3:465-468.